The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility
Kiuchi, T., Ortiz-Zapater, E., Monypenny, J., Matthews, D. R., Nguyen, L. K., Barbeau, J., Coban, O., Lawler, K., Burford, B., Rolfe, D. J., de Rinaldis, E., Dafou, D., Simpson, M. A., Woodman, N., PiVolume:
7
Language:
english
Journal:
Science Signaling
DOI:
10.1126/scisignal.2005157
Date:
August, 2014
File:
PDF, 2.92 MB
english, 2014